| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |